ALACRiS Theranostics GmbH

@Alacris Theranostics GmbH Innovation leader in precision oncology! We want every cancer patient to have a bright future Join the Forefront of Cancer Molecular Diagnostics Our mission is to empower every cancer patient with the benefits of precision medicine. With a passionate team translating research into patient-centered diagnostic solutions, we offer best-in-class accredited Dx services that combine state-of-the-art Next Generation Sequencing (NGS) with our proprietary bioinformatics pipeline. Unleash the Power of Comprehensive Tumor Profiling Experience a unique personalized Dx with our flagship solution, the Alacris-CMTA-TM (Comprehensive Molecular Tumor Analysis). By seamlessly integrating genomics and bulk transcriptomics, our ISO 15189 accredited...

Virtual patient modeling,precision medicine,virtual clinical trials,cancer diagnostics,precision oncology,ngs services,bioinformatics services,biomarker discovery,comprehensive molecular profiling ,transcriptomics,metagenomics,and genomics

Alacris theranostics gmbh operates in the Biotechnology research industry.

Alacris theranostics gmbh's revenue is 11m - 100m

Alacris theranostics gmbh has 11 - 50 employees.